Evidence map›Paper›PMID 29427734›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2018

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis.

George Cholankeril, Humberto C Gonzalez, Sanjaya K Satapathy, Stevan A Gonzalez, Menghan Hu, Mohammad Ali Khan, Eric R Yoo, Andrew A Li, Donghee Kim, Satheesh Nair and 6 more

Open access · greenAbstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Clinical and Biochemical Characteristics of a Danish and Turkish Cohort of Incident and Prevalent Patients with Primary Biliary Cholangitis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Assessing Interactions betweenInternational journal of environmental research and public health · 2021
    Article
  9. Impact of Payer Status on Delisting Among Liver Transplant Candidates in the United States.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Emerging therapies for PBC.Journal of gastroenterology · 2020
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

George CholankerilDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California.
Humberto C GonzalezDepartment of Transplant Surgery, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, Tennessee.
Sanjaya K SatapathyDepartment of Transplant Surgery, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, Tennessee.
Stevan A GonzalezBaylor Simmons Transplant Institute, Fort Worth, Texas.
Menghan HuDepartment of Biostatistics, Brown University School of Public Health, Providence, Rhode Island.
Mohammad Ali KhanDepartment of Transplant Surgery, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, Tennessee.
Eric R YooDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California.
Andrew A LiDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California.
Donghee KimDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California.
Satheesh NairDepartment of Transplant Surgery, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, Tennessee.
Robert J WongDivision of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, California.
Paul Y KwoDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California.
Stephen A HarrisonRadcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Zobair M YounossiDepartment of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Virginia.
Keith D LindorDivision of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Arizona State University, Phoenix, Arizona.
Aijaz AhmedDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California. Electronic address: aijazahmed@stanford.edu.
Stanford University · USUniversity of Tennessee Health Science Center · USAlameda Health System · USBrown University · USInova Fairfax Hospital · USMayo Clinic in Arizona · USStanford Medicine · USUniversity of Oxford · GB

Funding

TRAINING GRANT IN ACADEMIC GASTROENTEROLOGYT32DK007056 · NIDDK · STANFORD UNIVERSITY · PI Natalie J. Torok · 1986 to 2026
$6.5M
NIDDK NIH HHS T32 DK007056
6 · The paper itself

Abstract

BACKGROUND &

aimsData on the differences in ethnicity and race among patients with primary biliary cholangitis (PBC) awaiting liver transplantation (LT) are limited. We evaluated liver transplant waitlist trends and outcomes based on ethnicity and race in patients with PBC in the United States.

methodsUsing the United Network for Organ Sharing (UNOS) registry, we collected data on patients with PBC on the liver transplant waitlist, and performed analysis with a focus on ethnicity and race-based variations clinical manifestations, waitlist mortality and LT rates from 2000 to 2014. Outcomes were adjusted for demographics, complications of portal hypertension, and Model for End-stage Liver Disease score at time of waitlist registration.

resultsAlthough the number of white PBC waitlist registrants and additions decreased from 2000 to 2014, there were no significant changes in the number of Hispanic PBC waitlist registrants and additions each year. The proportion of Hispanic patients with PBC on the liver transplant waitlist increased from 10.7% in 2000 to 19.3% in 2014. Hispanics had the highest percentage of waitlist deaths (20.8%) of any ethnicity or race evaluated. After adjusting for demographic and clinical characteristics, Hispanic patients with PBC had the lowest overall rate for undergoing LT (adjusted hazard ratio, 0.71; 95% CI, 0. 60-0.83; P < .001) and a significantly higher risk of death while on the waitlist, compared to whites (adjusted hazard ratio, 1.41; 95% CI, 1.15-1.74; P < .001). Furthermore, Hispanic patients with PBC had the highest proportion of waitlist removals due to clinical deterioration.

conclusionsIn an analysis of data from UNOS registry focusing on outcomes, we observed differences in rates of LT and liver transplant waitlist mortality of Hispanic patients compared with white patients with PBC. Further studies are needed to improve our understanding of ethnicity and race-based differences in progression of PBC.

Indexed as

Waiting ListsAdolescentAdultAgedAged, 80 and overFemaleHispanic or LatinoHumansLiver Cirrhosis, BiliaryLiver TransplantationMaleMiddle AgedProcedures and Techniques UtilizationRace FactorsRetrospective StudiesUnited StatesMELDOPTNPBCUNOS

Identifiers

PMID29427734
PMCPMC7331901
OpenAlexW2785686756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.